HIMS 12-DAY DEADLINE ALERT: Hims & Hers Health Faces Securities Fraud Class Action, Investors with Losses Encouraged to Contact Hagens Berman
SAN FRANCISCO, Oct. 21, 2026 /PRNewswire/ -- Hims & Hers Health, Inc. (NYSE: HIMS) and certain company executives now face a securities class action lawsuit stemming from the FTC's sweeping federal complaint against the company in which the Commission accuses Hims of serious business...
Covered in this story
Analyst targets on Hims Hers Health Inc Class a
- Truist Securities: $28.5 → $32 by Oct 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $HIMS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Hims Hers Health Inc Class a →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.